Clot burden score on admission T2*-MRI predicts recanalization in acute stroke

Laurence Legrand1, Olivier Naggara, Guillaume Turc

  • 1Department of Radiology, Centre Hospitalier Sainte-Anne, Université Paris Descartes Sorbonne Paris Cité, Centre de Psychiatrie et Neurosciences, INSERM S894, Paris, France.

Stroke
|May 25, 2013
PubMed
Abstract

Insights

A new T2*-weighted MRI clot burden score (CBS) accurately predicts recanalization and outcomes in stroke patients receiving intravenous thrombolysis. This reproducible score helps identify patients unlikely to respond well to treatment.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Acute ischemic stroke treatment relies on reperfusion therapies.
  • Computed tomography angiography (CTA) clot burden score (CBS) aids in predicting treatment response.
  • A non-contrast MRI adaptation is needed for broader clinical application.

Purpose of the Study:

  • To adapt the CTA-CBS for T2*-weighted MRI (T2*-CBS).
  • To evaluate T2*-CBS as a predictor of 24-hour recanalization and clinical outcome.
  • To assess T2*-CBS in anterior circulation stroke patients treated with intravenous thrombolysis.

Main Methods:

  • Retrospective analysis of pretreatment T2*-weighted MRI scans in 184 stroke patients.
  • Application of a 10-point T2*-CBS based on susceptibility vessel sign presence and location.
  • Multivariate analyses to assess associations between T2*-CBS and recanalization/outcome.

Main Results:

  • High inter-observer reliability for T2*-CBS (ICC=0.97).
  • A T2*-CBS >6 was significantly associated with 24-hour recanalization (aOR=5.1) and favorable 3-month outcome (aOR=4.2).
  • Patients with T2*-CBS >6 showed improved outcomes after thrombolysis.

Conclusions:

  • T2*-CBS is a reproducible MRI-based score predicting recanalization and outcome.
  • This score can identify patients who may not benefit from intravenous thrombolysis.
  • External validation is recommended for widespread clinical adoption.